Comprehensive Partnerships to Reduce Cancer Health Disparities (U54)

The summary for the Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Comprehensive Partnerships to Reduce Cancer Health Disparities (U54): Purpose. The National Cancer Institute (NCI) solicits cooperative agreement (U54) applications for the implementation of Comprehensive Partnerships between institutions serving communities with cancer health disparities and NCI-designated Cancer Centers (or groups of Centers). The purpose of this funding opportunity announcement (FOA) is to foster and support intensive collaborations among institutions that serve communities with cancer health disparities in order to develop stronger national cancer programs aimed at understanding the reasons behind the significant cancer disparities and related impacts on these populations. This FOA is intended for: (1) extending the support under the U54 mechanism for the best of the currently funded Comprehensive Partnerships; and (2) elevating to the full Comprehensive Partnership status the most promising partnerships currently in the planning/developing phase (supported by U56 awards). Mechanism of Support. This FOA will utilize the National Institutes of Health (NIH) specialized center cooperative agreement (U54) award. Funds Available and Anticipated Number of Awards. The NCI intends to commit approximately $6.25 million in total costs in FY11 to fund four (two pairs) or five (one pair and one triad) new and/or renewal applications in response to this FOA.

Federal Grant Title:	Comprehensive Partnerships to Reduce Cancer Health Disparities (U54)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-CA-11-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.393
CFDA Descriptions:	Cancer Cause and Prevention Research
Current Application Deadline:	Jan 06, 2011
Original Application Deadline:	Jan 06, 2011
Posted Date:	Oct 14, 2010
Creation Date:	Oct 14, 2010
Archive Date:	Feb 06, 2011
Total Program Funding:	$6,250,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; NCI-designated Cancer Centers (or group of centers); and Other Institutions serving populations affected by health disparities
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional); • Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required); • National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer ...; • Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Cli...; • Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...; • Pilot Studies in Pancreatic Cancer; • Cancer Prevention Research Small Grant Program; • Molecular Targets for Nutrients in Prostate Cancer Prevention
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...